At the time of writing, Envoy Medical Inc [COCH] stock is trading at $0.88, down -6.75%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The COCH shares have gain 8.72% over the last week, with a monthly amount drifted -33.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Envoy Medical Inc [NASDAQ: COCH] stock has seen the most recent analyst activity on June 24, 2024, when Ascendiant Capital Markets initiated its Buy rating and assigned the stock a price target of $8.50.
For the past year, the stock price of Envoy Medical Inc fluctuated between $0.74 and $3.11. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Envoy Medical Inc [NASDAQ: COCH] shares were valued at $0.88 at the most recent close of the market. An investor can expect a potential return of 581.82% based on the average COCH price forecast.
Analyzing the COCH fundamentals
According to Envoy Medical Inc [NASDAQ:COCH], the company’s sales were 0.22M for trailing twelve months, which represents an 14.71% jump. Gross Profit Margin for this corporation currently stands at -2.62% with Operating Profit Margin at -88.63%, Pretax Profit Margin comes in at -95.79%, and Net Profit Margin reading is -95.79%. To continue investigating profitability, this company’s Return on Assets is posted at -2.15, Equity is 0.93 and Total Capital is -10.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Envoy Medical Inc [NASDAQ:COCH] has a current ratio of 0.94. Further, the Quick Ratio stands at 0.74, while the Cash Ratio is 0.66. Considering the valuation of this stock, the price to sales ratio is 95.77.
Transactions by insiders
Recent insider trading involved Patel Mona Chetan, Director, that happened on Jun 11 ’25 when 2500.0 shares were purchased. Director, Patel Mona Chetan completed a deal on Jun 06 ’25 to buy 10000.0 shares. Meanwhile, Director BRYNELSEN CHARLES bought 35000.0 shares on May 27 ’25.
